Biliary cancers, chemotherapy, and cetuximab.
David
D
Malka
Valérie
V
Boige
Michel
M
Ducreux
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001661:Biliary Tract Neoplasms / Q000188:drug therapy*; D000068818:Cetuximab; D002986:Clinical Trials as Topic; D006801:Humans; D012106:Research
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab